Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026)
Lemaitre Vascular (LMAT) reported Cash from Investing Activities of -$13.1 million for Q1 2026, down 203.73% year-over-year from $12.6 million in Q1 2025, and up 22.01% quarter-over-quarter from -$16.8 million in Q4 2025.
Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Lemaitre Vascular (LMAT) has 17 years of Cash from Investing Activities data on file, last reported at -$13.1 million in Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$13.1 million, down 203.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$73.7 million (up 63.51% YoY), and the FY2025 annual result was -$64.9 million, up 67.55% from the prior year.
- Cash from Investing Activities grew to -$13.1 million in Q1 2026 per LMAT's latest filing, from -$16.8 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$402000.0 in Q4 2022 and troughed at -$173.9 million in Q4 2024.
- A 5-year average of -$18.4 million and a median of -$9.6 million in 2023 frame the typical range for Cash from Investing Activities.
- The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities surged 94.45% in 2022, then sank 7590.93% in 2024.
- A 5-year view of Cash from Investing Activities shows it stood at -$402000.0 in 2022, then plunged by 462.44% to -$2.3 million in 2023, then slumped by 7590.93% to -$173.9 million in 2024, then soared by 90.32% to -$16.8 million in 2025, then gained by 22.01% to -$13.1 million in 2026.
- Business Quant data shows LMAT's Cash from Investing Activities at -$13.1 million in Q1 2026, -$16.8 million in Q4 2025, and -$27.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Lemaitre Vascular | 2.12 Bn | 1.75 Bn | 48.40 Mn | -13.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.12 Mn |
| Mar 31, 2026 | -13.12 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Dec 31, 2025 | -16.83 Mn |
| Sep 30, 2025 | -27.45 Mn |
| Sep 30, 2025 | -27.45 Mn |
| Jun 30, 2025 | -16.35 Mn |
| Jun 30, 2025 | -16.35 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Mar 31, 2025 | -4.32 Mn |
| Dec 31, 2024 | -173.89 Mn |
| Dec 31, 2024 | -173.89 Mn |
| Sep 30, 2024 | -12.86 Mn |
| Sep 30, 2024 | -12.86 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | -2.36 Mn |
| Mar 31, 2024 | -2.36 Mn |
| Dec 31, 2023 | -2.26 Mn |
| Dec 31, 2023 | -2.26 Mn |